Agri research must benefit farmers on field: Andhra Minister Lavu
He paid floral tributes to the statue of Acharya NG Ranga and recalled his pioneering contributions to Indian agriculture and rural development. Speaking at the Diamond Jubilee celebrations of Acharya NG Ranga Agricultural University (ANGRAU) campus in Guntur, he lauded the university's distinguished history, strong infrastructure, and dedicated scientific community.
'Institutions like ANGRAU should strive to make their research accessible and practical. The technologies and findings developed here must empower farmers on the ground,' he said, adding that scalable, pest-resistant solutions are critical for large-scale implementation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
40 minutes ago
- NDTV
Global First: Indian Scientists Map Cervical Cancer At Molecular Level, Open Doors To Precision Treatment
In a landmark achievement that places India firmly on the global oncology map, a team of Indian scientists and clinicians has conducted the country's first-ever integrative genomic and phosphoproteomic analysis of cervical cancer. This pioneering research, based on patient samples from Bihar, a state heavily impacted by the disease, unravels why some patients fail to respond to standard treatments and suggests more effective, personalised alternatives. Led by PhD scholars Janani Sambath and Irene A. George under the mentorship of Dr. Prashant Kumar, this study represents the world's first whole-genome and global proteomics-phosphoproteomics mapping of cervical cancer. On the clinical front, Dr. Richa Chauhan, senior oncologist at Mahavir Cancer Sansthan, Patna, monitored the application of these findings in real-world scenarios. "This research is close to my heart," says Dr. Chauhan. "As a cancer physician, I see women every day, many from rural or underserved backgrounds, with late-stage cervical cancer. Being part of a study that not only decodes resistance but also proposes actionable solutions is deeply gratifying." Revealing The Genetic Drivers Of Resistance Using advanced DNA sequencing, the researchers identified two major genetic alterations common in treatment-resistant cervical tumours: An increase in the number of copies of the EGFR gene, which accelerates cancer cell growth and spread. The loss of the STK11 gene, which normally functions as a growth brake. These findings are clinically significant as EGFR can be targeted using existing cancer drugs, potentially offering life-saving treatment options for patients unresponsive to standard therapy. Proteins That Hold The Key The proteomics arm of the study revealed that the CSNK2A1 protein acts as a "master switch" in treatment-resistant tumours, enabling survival pathways. Blocking this protein with the drug silmitasertib, in combination with low-dose cisplatin, significantly reduced cancer growth in lab experiments. In parallel, the phosphoproteomics analysis uncovered another protein-STX3-consistently present at high levels in resistant tumours. Identified as a powerful biomarker, STX3's discovery has been patented by the Government of India (Patent No. 404113) and has garnered widespread national attention. Recognition On The Global Stage Dr. Prashant Kumar presented the study at the ESMO Asia Congress 2024 in Singapore, where it earned the prestigious Best Poster Award, competing against top cancer research teams worldwide. This recognition not only validates the scientific excellence of the work but also strengthens India's position in the fight against women's cancers. "This is not just a scientific achievement, it's a social imperative," says Dr. Kumar. "We're proud that our research, powered by Indian samples and minds, is creating real translational possibilities." Why It Matters For India: Cervical Cancer Impact On Indian Women Cervical cancer is the second most common cancer among Indian women, responsible for nearly 10% of all female cancer cases. Despite HPV vaccination efforts, rural states like Bihar continue to face late-stage diagnoses, underscoring the urgent need for early detection tools and improved treatment protocols. Cervical cancer begins in the cervix-the lower part of the uterus-and is typically driven by long-term infection with high-risk human papillomavirus (HPV) types, especially HPV-16 and 18. Often slow to show symptoms, it may initially involve irregular or abnormal vaginal bleeding, making regular screening (via Pap smears or HPV tests) vital for early detection and successful treatment. Globally, it ranks as the fourth most common cancer in women, with over 600,000 new cases and nearly 342,000 deaths reported in 2020. In India, the burden is even higher: age-standardised incidence is about 14.7 per 100,000 women, with a mortality rate of 9.2 per 100,000, as another study published in BMC Cancer in 2022 suggests. Roughly 96,900 new cases are diagnosed annually, with 60,000-67,000 deaths, accounting for about one-fifth of global cervical cancer burden. The five-year survival rate in India hovers around 47%, significantly lower than figures in more developed countries. Vulnerable groups, such as women from lower socioeconomic strata, rural areas, and with limited education, are disproportionately affected. Incidence rates peak among women aged 50-59, especially in regions like Northeast India, with cities like Aizawl reporting rates as high as 24 per 100,000. Alarmingly, screening rates remain abysmally low. Data from NFHS-5 shows only about 1-2% of women have ever undergone cervical cancer screening. This wide gap in awareness and access underscores a pressing public health priority. Keeping these in mind, the team behind the new breakthrough study aims to move silmitasertib-based combination regimens into clinical trials, alongside the development of targeted clinical tests to guide treatment planning. With its blend of cutting-edge molecular science and deep compassion for patients, this research offers renewed hope to thousands of women who need it most.
Deccan Herald
3 hours ago
- Deccan Herald
Back from the stars: Shubhanshu Shukla to land in India after ISS mission
Group Captain Shubhanshu Shukla, the first Indian to visit the International Space Station, is back and set to meet PM Modi in Delhi before heading to Lucknow, and will be back in the capital for National Space Day on August 23.
Indian Express
4 hours ago
- Indian Express
2 Indian aquanauts make record-breaking dives into Atlantic Ocean
In preparation for the country's Deep Ocean Mission, two Indian aquanauts have undertaken dives to nearly 4,000 metres and 5,000 metres in the Atlantic Ocean, on board the French vessel, Nautile. These are the deepest ocean dives ever made by Indians, with most submarine dives being restricted to above 500 metres, and a previous record of 670 metres being set by aquanaut Commander (Retd) Jatinder Pal Singh. The dives took place on August 4 and 5. While Singh descended 5,002 metres, R Ramesh descended to 4,025 metres. An Indian flag, along with a French one, was floated during the dive. From deployment to retrieval, the mission to travel to the depths of 5,000 metres took about 9.5 hours. 'It took about two and a half hours to reach the depth. Once there, I spent around four hours at the depth working with the robotic arm, checking how to work with and without the light at a place where there is never any sunlight, how to work with the life support system if the CO2 systems are shut off, what has to be done in case of power failure, or how long will it take for the vessel to reach the surface in case of an emergency,' said Singh, who was a Naval submarine pilot. The experience from the two dives would help India's upcoming Samudrayaan mission. India plans to build its vessels to send three aquanauts to the depths of 6,000 metres by 2027. 'These dives was meant for our team to gain hands on experience on several aspects of such deep sea missions such as pre-dive preparatory tasks, piloting the vessel, ascending, descending and living in the vessel, using the robotic manipulator to collect samples from the outside, tracking the vessel, and retrieving it after the mission,' said Dr M Ravichandran, Secretary, Department of Earth Sciences. Another important learning from the dives was on communication protocols with the use of acoustic telephones. 'Thousands of metres underwater, you cannot use normal communication methods. Our phones use air as a medium to transmit radio waves to enable communication; these cannot penetrate the depth of water. So, for underwater communication, sound waves are used, and there is a delay of a few seconds in that,' Ravichandran said. The collaboration with France came after years of negotiation, as most countries are reluctant to share deep-sea technologies. In fact, India developed its own acoustic phones and will manufacture the titanium sphere that will carry the aquanauts. 'For depths of 6,000 metres, a titanium sphere will be needed for the crew. This sphere is currently being manufactured by the Indian Space Research Organisation,' he said, adding that it requires highly specialised and precise manufacturing techniques. He explained that the sphere has to be of 80mm thickness uniformly, 'even if at one place it is 79.8 mm thick, it will collapse under the immense pressure'. Under the Samudrayaan mission, a shallow water dive up to 500 metres—using a steel sphere instead of the more complex titanium one—is likely to take place in mid-2026. The integration of the titanium sphere and deep water testing is likely to occur by mid-2027, before the final mission scheduled for 2027-28.
